Loading...
DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
BACKGROUND: The use of direct oral anticoagulants (DOACs) is a convenient therapeutic option for patients at risk of thrombosis. DOACs interfere with clot‐based testing for the identification of lupus anticoagulant antibodies (LACs) in patients with antiphospholipid syndrome (APS), a common cause of...
Na minha lista:
| Udgivet i: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7938630/ https://ncbi.nlm.nih.gov/pubmed/33733031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12472 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|